Article thumbnail

Glibenclamide or Metformin Combined with Honey Improves Glycemic Control in Streptozotocin-Induced Diabetic Rats

By Omotayo Owomofoyon Erejuwa, Siti Amrah Sulaiman, Mohd Suhaimi Ab Wahab, Kuttulebbai Nainamohammed Salam Sirajudeen, Md Salzihan Md Salleh and Sunil Gurtu


Diabetes mellitus is associated with deterioration of glycemic control and progressive metabolic derangements. This study investigated the effect of honey as an adjunct to glibenclamide or metformin on glycemic control in streptozotocin-induced diabetic rats. Diabetes was induced in rats by streptozotocin. The diabetic rats were randomized into six groups and administered distilled water, honey, glibenclamide, glibenclamide and honey, metformin or metformin and honey. The animals were treated orally once daily for four weeks. The diabetic control rats showed hypoinsulinemia (0.27 ± 0.01 ng/ml), hyperglycemia (22.4 ± 1.0 mmol/L) and increased fructosamine (360.0 ± 15.6 µmol/L). Honey significantly increased insulin (0.41 ± 0.06 ng/ml), decreased hyperglycemia (12.3 ± 3.1 mmol/L) and fructosamine (304.5 ± 10.1 µmol/L). Although glibenclamide or metformin alone significantly (p < 0.05) reduced hyperglycemia, glibenclamide or metformin combined with honey produced significantly much lower blood glucose (8.8 ± 2.9 or 9.9 ± 3.3 mmol/L, respectively) compared to glibenclamide or metformin alone (13.9 ± 3.4 or 13.2 ± 2.9 mmol/L, respectively). Similarly, glibenclamide or metformin combined with honey produced significantly (p < 0.05) lower fructosamine levels (301.3 ± 19.5 or 285.8 ± 22.6 µmol/L, respectively) whereas glibenclamide or metformin alone did not decrease fructosamine (330.0 ± 29.9 or 314.6 ± 17.9 µmol/L, respectively). Besides, these drugs or their combination with honey increased insulin levels. Glibenclamide or metformin combined with honey also significantly reduced the elevated levels of creatinine, bilirubin, triglycerides, and VLDL cholesterol. These results indicate that combination of glibenclamide or metformin with honey improves glycemic control, and provides additional metabolic benefits, not achieved with either glibenclamide or metformin alone

Topics: Research Paper
Publisher: Ivyspring International Publisher
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (1972). An improved color reagent for the determination of blood glucose by the oxidase system. Analyst.
  2. (2010). Antioxidant protection of Malaysian tualang honey in pancreas of normal and streptozotocin-induced diabetic rats. Ann Endocrinol.
  3. (2010). Antioxidant status of a polyherbomineral formulation (Gly-13-C) in STZ-diabetic rats.
  4. (1999). Beneficial effects of antioxidants in diabetes: possible protection of pancreatic -cells against glucose toxicity. Diabetes.
  5. (2004). Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes.
  6. (1998). Clinical laboratory diagnostics, 1st ed.
  7. (1985). Comparison of improved precipitation methods for quantification of high-density lipoprotein cholesterol. Clin Chem.
  8. (1981). CuZn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse. Biochem J.
  9. (2002). Defining the relationship between plasma glucose and HbA1c. Diabetes Care.
  10. (1995). Diabetes Study Group. UK Prospective Diabetes Study 16: Overview of 6 years’ therapy of type II diabetes: a progressive disease. Diabetes.
  11. (1999). Dyslipidemia in diabetes mellitus. Review of the main lipoprotein abnormalities and their consequences on the development of atherogenesis. Diabetes Metab.
  12. (2002). Effect of honey on the growth of and acid production by humann intestinal Bifidobacterium spp.: An in vitro comparison with commercial oligosaccharides and inulin. J Food Protect.
  13. (1980). Effects of bees honey, zahdi dates and its syrup on blood glucose and serum insulin of diabetics. Nutr Rep Int.
  14. (1963). Effects of carbohydrates on secretion of insulin from isolated rat pancreas.
  15. (2009). Effects of Malaysian tualang honey supplementation on glycemia, free radical scavenging enzymes and markers of oxidative stress in kidneys of normal and streptozotocin-induced diabetic rats.
  16. (2009). Effects of natural honey consumption in diabetic patients: an 8-week randomized clinical trial. Int J Food Sci Nutr.
  17. Effects of Simvastatin on Oxidative Stress in Streptozotocin-Induced Diabetic Rats: A Role for Glomeruli Protection. Nephron Exp Nephrol.2005;101:e1-e8.
  18. (1997). Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes.
  19. (1972). Estimation of the concentration of LDL-C in plasma without use of the preparative ultracentrifuge. Clin Chem.
  20. (2000). Fatty liver and hyperlipidemia in IDDM (insulin-dependent diabetes mellitus) of Streptozotocin-treated shrews. Life Sci.
  21. (1972). Fructose potentiation of insulin secretion. Endocrinology.
  22. (1981). Functional and morphological renal manifestations in diabetes mellitus. Diabetologia.
  23. (2006). glucose toxicity, and oxidative stress: a case of double jeopardy for the pancreatic islet beta cell. Free Radic Biol Med.
  24. High-fructose corn syrup causes characteristics of obesity in rats: Increased body weight, body fat and triglyceride levels. Pharmacol Biochem Behav. 2010; [Epub ahead of print].
  25. (2008). Honey for nutrition and health: a review. J Am Coll Nutr.
  26. (2009). Hypolipidemic activity of 18β-glycyrrhetinic acid on streptozotocin-induced diabetic rats.
  27. (2005). In vitro investigation into the potential prebiotic activity of honey oligosaccharides. J Agric Food Chem.
  28. (1994). In vivo regulation of lipolysis in humans. J Lipid Res.
  29. (1996). Inhibition of protein glycation and advanced glycation end products by ascorbic acid and other vitamins and nutrients.
  30. (1982). Insulin: the effects and mode of action of the hormone. Vitamins and Hormones.
  31. (1998). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet.
  32. (1993). Intermediary metabolism of fructose.
  33. (2006). Metformin reduces blood pressure and restores endothelial function in aorta of streptozotocin-induced diabetic rats. Life Sci.
  34. (1984). Non-enzymatic glycosylation and the chronic complications of diabetes: an overview. Diabetologia.
  35. (2005). Oral antidiabetic agents: current role in type 2 diabetes mellitus. Drugs.
  36. (1999). Preliminary studies on the inorganic constituents of some indigenous hyperglycaemic herbs on oral glucose tolerance test. J Ethnopharmacol.
  37. (2002). Probiotics and prebiotics: a brief overview.
  38. (1983). Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem.
  39. (2004). Role of oxidative stress in pancreatic beta-cell dysfunction.
  40. (2002). Small amounts of dietary fructose dramatically increase hepatic glucose uptake through a novel mechanism of glucokinase activation. Nutr Rev.
  41. (1973). Stable reagents for determination of serum triglycerides by colorimetric hantzsch condensation method. Clin Chem.
  42. (1963). Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemother Rep.
  43. (2008). The antidiabetic effects of cysteinyl metformin, a newly synthesized agent, in alloxan- and streptozocin-induced diabetic rats. Chem Biol Interact.
  44. (1999). The antihyperglycaemic effect of metformin: therapeutic and cellular mechanisms. Drugs.
  45. (1993). The Diabetes Control and Complications Trial (DCCT) Research Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in the diabetes control in insulin dependent diabetes mellitus.
  46. (2001). The effect of a thiazolidinedione drug, troglitazone, on glycemia in patients with type 2 diabetes mellitus poorly controlled with sulfonylurea and metformin; a multicenter, randomized, double-blind, placebo-controlled trial. Ann Intern Med.
  47. (1978). The effect of zinc on insulin metabolism. Endocrinology.
  48. (2009). The glycemic and peak incremental indices of honey, sucrose and glucose in patients with type 1 diabetes mellitus: effects on C-peptide level—a pilot study. Acta Diabetol.
  49. (1934). The role of copper in carbohydrate metabolism.
  50. (2005). UK Prospective Diabetes Study (UKPDS) Group. Glycemic control continues to deteriorate after sulfonylureas are added to metformin among patients with type 2 diabetes. Diabetes Care.
  51. (1999). UK Prospective Diabetes Study Group. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). JAMA.
  52. (1991). Vitamin E reduction of protein glycosylation in diabetes: new prospect for prevention of diabetic complications? Diabetes Care.